Industry Research and Development (Onshore Gas Social and Economic Research Fund Program) Instrument 2017

The instrument is structured around a small set of discrete legal concepts. Each is limited by the instrument’s brevity and by the explicit cross-reference to the Industry Research and Development Act 1986.

Prescribed program (s 5)

• The core concept is the “prescribed program”. The instrument prescribes one such program, named the Onshore Gas Social and Economic Research Fund Program. The prescription serves the specific legal purpose identified in subsection 33(1) of the Act; the instrument states that it is prescribing the program “for the purposes of subsection 33(1) of the Act” (s 5). The instrument conveys that prescription by naming the program, identifying the recipient and setting out the program’s objects.

Grant to CSIRO (s 5 table)

• The program is described as “Grant to the Commonwealth Scientific and Industrial Research Organisation”. That description is the practical vehicle through which the Commonwealth’s interest is expressed. The instrument’s text confines the program’s activities to two stated aims: undertaking scientific research relating to social, economic and environmental impacts of Australia’s onshore natural gas industry, and communicating the results of that research (s 5 table, Column 2, items (a) and (b)).

Authority and statutory footing (s 3 and s 6)

• The instrument explicitly states it is made under section 33 of the Industry Research and Development Act 1986 (s 3). Section 6 then specifies the legislative power to which the prescription is tied: laws “peculiarly adapted to the government of a nation and cannot otherwise be carried on for the benefit of the nation” (s 6). The instrument therefore links the program prescription to particular parliamentary legislative power for the purposes of subsection 33(3) of the Act.

Commencement detail and legal effect (s 2)

• The instrument contains a commencement table. It declares the whole instrument commences or is taken to have commenced the day after registration; the table records 27 June 2017 as the date in column 3 (s 2 and commencement table). The instrument also states that column 3 information is not part of the instrument; that text appears as a standalone note in s 2. The practical effect is that the instrument’s legal operation begins on the specified commencement but the calendar date in column 3 is informative rather than operative text.

Limited definitional scope (s 4)

• The only definitional provision is that “Act” means the Industry Research and Development Act 1986 (s 4). The instrument therefore relies on the Act for any further meaning, processes or consequences, and does not define other terms used in the prescription.

Absence of operational detail

• The instrument does not set out operational mechanics of grant administration. It does not specify amounts, duration, reporting obligations, performance criteria, auditing, public disclosure measures, conflict of interest or IP terms. It does not set out enforcement mechanisms or sanctions. Those matters will, insofar as they exist, derive from the Act, from grant agreements or from administrative practice external to the instrument itself.

Taken together, these concepts show the instrument functions as a narrowly focused statutory vehicle that brings a named research grant programme and its stated aims within the scope of the Industry Research and Development Act 1986, tied to a particular legislative power, but leaves operational and financial detail to other instruments or agreements.

The instrument identifies a small set of named and implied stakeholders by prescribing the program and its objectives. The text itself names one beneficiary and sets out the fields of enquiry targeted by the grant; it does not create broad statutory rights or duties for third parties. From the instrument’s content, the affected parties and their roles can be stated as follows.

Commonwealth Scientific and Industrial Research Organisation (CSIRO)

• The instrument expressly prescribes a program described as a “Grant to the Commonwealth Scientific and Industrial Research Organisation” (s 5 table, Column 2). CSIRO is therefore the named recipient of the programme prescription. That is the single explicit institutional addressee in the instrument.

Communities, industries and subject-matter groups relevant to onshore natural gas

• The program’s subject matter is “the social, economic and environmental impacts of Australia’s onshore natural gas industry” and the communication of results (s 5 table). That phrase identifies the social groups, economic actors and environmental interests whose conditions or activities will be the focus of the prescribed research. Those actors are affected as subjects of research and as potential audiences for outcomes and communications, even though the instrument does not create enforceable entitlements for them.

Commonwealth executive and Parliament

• The instrument is made under s 33 of the Industry Research and Development Act 1986 (s 3). It therefore affects the Commonwealth executive’s programmatic landscape under the Act by adding this program to the list of prescribed programs for the Act’s purposes. Parliament’s legislative power is addressed in s 6 where the instrument specifies the legislative power relied upon for the prescription; the instrument therefore identifies the constitutional or parliamentary basis that determines the extent of the prescription.

Administrators and fund managers (unspecified in instrument)

• Although the instrument does not name an administrative agency beyond CSIRO, in practice the administration of the grant, the making of grant agreements, and any reporting will require administrative actors. The instrument itself does not specify who will prepare or execute grant agreements, nor does it set terms for grant administration. Consequently, bodies that administer grants under the Act or the Commonwealth’s financial framework may be indirectly affected when implementing the program although they are not named in the instrument.

Researchers and research partners

• The program’s content , scientific research into social, economic and environmental impacts, and communication of results , implies that personnel, contractors, research partners and collaborators engaged by CSIRO to carry out the research will be affected by the programme’s existence. The instrument does not specify eligibility, procurement or engagement rules for those participants; it simply identifies the activities to be supported (s 5).

States, territories and regulators (implicitly)

• The subject matter relates to onshore natural gas, an area of public policy where states, territories and regulators may have statutory responsibilities. The instrument does not name them, but the research could implicate their regulatory regimes and operations. The instrument contains no specific direction about consultation, data-sharing or legal interaction with those jurisdictions.

Members of the public and stakeholders in communication

• The program’s second stated aim is the communication of research results (s 5 table, item (b)). That aim identifies the public, stakeholder groups, industry participants and policy-makers as intended audiences, which means those groups are affected in the sense that outputs of the programme are to be communicated to them.

Not affected in terms of explicit statutory obligations

• The instrument does not impose duties, obligations or financial liabilities on private entities outside of naming CSIRO as the recipient. No private person or company is placed under an express statutory duty by the instrument’s text. Any duties that arise as a consequence of grant agreements or administrative arrangements are external to this instrument.

In short, the instrument directly affects CSIRO as the named recipient, and indirectly affects entities and stakeholders who will be the subjects of research or the audiences for communicated results. The instrument does not itself create enforceable rights or obligations for those third parties; it functions as the statutory prescription bringing a specified grant and research purpose within the machinery of the Industry Research and Development Act 1986.

The instrument is terse and does not itself create a broad regime of duties, rights or penalties. Its legal effect is to prescribe a program by reference to the Industry Research and Development Act 1986. The instrument therefore establishes the programme’s existence and purpose rather than prescribing operational obligations. From the text, the following observations about duties and rights can be made.

No express statutory duties or rights in the instrument

• The instrument does not set out obligations to be performed by CSIRO, by research participants, or by third parties. It does not create statutory rights such as a private right to compel publication, public access to data, or a cause of action for non-performance. The text confines itself to prescribing the program and relating its purpose (s 5). Any duties and rights that govern performance, reporting, publication, data access or other operational matters are not contained within this instrument.

CSIRO as the named recipient

• The prescription identifies CSIRO as the recipient of the grant (s 5 table). That naming implies CSIRO will be the party to receive funds and undertake activities described, but the instrument does not specify the form or terms of any grant agreement, nor does it specify performance obligations, reporting timelines, intellectual property arrangements, or accountability measures.

Dependence on the Act for legal mechanics

• Because the instrument is made under s 33 of the Industry Research and Development Act 1986 (s 3) and expressly references subsection 33(1) and subsection 33(3) in its prescription and specification of legislative power, the rights and duties that matter in practice will be those set out in the Act and any administrative instruments or grant agreements made under it. The instrument’s definitional provision only defines the Act itself (s 4); it relies on the Act for process and power.

Communication duty implied by the program description

• The program’s stated purpose includes “the communication of the results of that research” (s 5 table, Column 2, item (b)). This expresses an expectation or objective that the grant-funded activities will include communication. The instrument does not, however, turn that expectation into a statutory duty with enforceable standards, timelines or channels; it sets the communication of results as a program purpose rather than as a prescriptive legal duty.

No express rights to compel access to research outputs

• Although communication of results is an identified program aim, the instrument does not create a statutory right for third parties or the public to receive those results, nor does it set formats, timing or mandatory dissemination obligations. Access arrangements will be a matter for grant terms or administrative policy outside the instrument.

Commencement and prospective effect

• The instrument commences in full the day after registration (s 2 and the commencement table). That commencement is the moment the programme is prescribed under the Act for the specified legislative power. Any duties or rights that derive from the Act’s operation in respect of prescribed programs therefore become relevant from that commencement, but they are not articulated within the instrument.

In summary, the instrument itself creates no detailed statutory duties or enforceable rights. It names CSIRO as the grant recipient and sets program purposes; the legal effect of duties and rights will depend on the Act and on separate grant agreements or administrative arrangements made under the Act. Those subsequent documents or statutory provisions will determine the practical obligations of CSIRO and the legal entitlements of other parties.

The instrument contains no provisions creating penalties, sanctions, enforcement mechanisms, compliance regimes, or criminal or civil consequences. It is a prescription instrument that identifies a research programme under the Industry Research and Development Act 1986 and specifies the legislative power for the purposes of that prescription. From the instrument’s text, the following points follow.

Absence of internal enforcement provisions

• There are no clauses within the instrument that specify enforcement, audit, inspection, suspension, recovery of funds, penalty payments, offences, or criminal sanctions. The instrument’s text is limited to identification of the program and its purpose (s 5).

Reliance on external legal frameworks

• Because the instrument is made under s 33 of the Industry Research and Development Act 1986 (s 3) and the prescription is for purposes of subsection 33(1) (s 5), any enforcement or compliance measures that might apply to the programme will derive from the Act itself, from Commonwealth financial management law, from grant agreements, or from administrative policies that are external to this instrument. The instrument does not reproduce or summarise any such measures.

No specified dispute resolution or review mechanisms

• The instrument does not provide for internal or external review, dispute resolution, merits review, or judicial review procedures in relation to decisions connected to the programme. Any right of review or challenge would therefore depend on general administrative law principles, the Act’s provisions, and the terms of any implemented grant agreements, none of which are set out in this instrument.

No statutory private enforcement rights

• The instrument does not create rights enabling private parties to bring enforcement actions for breach of program commitments or for failure to communicate research outcomes. It simply prescribes the program and its aims.

Commencement affects when any external enforcement becomes relevant

• The instrument commenced the day after registration (s 2 and table). That commencement is the point at which the program is formally prescribed under the Act for the specified legislative power. Any enforcement or compliance obligations deriving from the Act or from grant agreements would therefore apply from the point at which the Act and agreements become operative in relation to the prescribed programme. Those mechanisms are not contained in the instrument.

Note on informational text in commencement table

• The instrument expressly states that the information in column 3 of the commencement table is not part of the instrument (s 2). This means the recorded date in column 3 is informational in the text but should not be treated as operative text within the instrument itself. The legal commencement remains the day after registration, as stated in the table in column 2; enforcement measures, where they exist externally, would be relevant from that operative commencement.

In short, the instrument does not itself authorise or describe enforcement tools. Any enforcement consequences in practice will be sourced from the Act, from grant terms and conditions, and from the Commonwealth’s general financial and administrative law frameworks.

The instrument is compact and interacts explicitly only with the Industry Research and Development Act 1986. Its text otherwise leaves open interactions with financial, administrative and constitutional law, but does not spell them out. The instrument’s explicit and implied interactions are as follows.

Direct statutory foundation under the Industry Research and Development Act 1986

• The instrument is made under section 33 of the Industry Research and Development Act 1986 (s 3). It explicitly states the program is prescribed “for the purposes of subsection 33(1) of the Act” (s 5). It also invokes subsection 33(3) by specifying the legislative power in s 6. Therefore the instrument’s immediate legal interaction is with s 33 and other relevant provisions of the Act. The Act will supply the statutory processes, powers and possibly financial authorities relevant to prescribed programs; the instrument itself does not restate those provisions.

Specification of legislative power (s 6)

• Section 6 specifies, for the purposes of subsection 33(3) of the Act, the legislative power on which the prescription is to be founded. The instrument’s language is that the legislative power “to make laws that are peculiarly adapted to the government of a nation and cannot otherwise be carried on for the benefit of the nation, is specified” (s 6). This is a textual interaction with constitutional or parliamentary allocation of power as invoked in the Act. The instrument thus ties its prescription to that specific legislative power for the Act’s purposes.

Financial and appropriations law (implicit)

• The instrument prescribes a “Grant to the Commonwealth Scientific and Industrial Research Organisation” (s 5 table). The instrument does not itself appropriate money, specify funding sources, or set financial management rules. The practical funding and expenditure for the programme must be consistent with Commonwealth appropriation and financial management law, however those frameworks are not set out in the instrument. The instrument does not displace or restate those financial law requirements.

Administrative law and grant agreements (implicit)

• The instrument does not set procedural or contractual terms. The actual disbursement, monitoring and administration of the grant will interact with administrative law principles, procurement rules, Commonwealth grants policies and any relevant terms in grant agreements. None of those instruments or rules are textually incorporated into this instrument.

State and territory law (implicit)

• The prescribed research concerns the onshore natural gas industry (s 5). Onshore resources are frequently the subject of state and territory regulation. The instrument does not specify how research activities, data-collection, or communication will interact with state or territory regulatory regimes or statutory obligations. Any overlap or conflict with state or territory law would need to be managed in practice, and the instrument does not prescribe mechanisms for doing so.

Intellectual property, privacy and disclosure regimes (implicit)

• The instrument requires communication of research results (s 5 table item (b)), but says nothing about ownership or licensing of intellectual property, privacy of research subjects, or confidential data protections. Those interactions will depend on the Act, on grant terms or separate administrative arrangements, none of which are contained in this instrument.

Commencement table note about column 3 (s 2)

• The instrument expressly states that information in column 3 of the commencement table is not part of the instrument (s 2). That statement narrows textual interaction by isolating administrative annotation (a recorded date) from operative text. It therefore separates the instrument’s internal legal text from ancillary publication metadata.

In summary, the instrument’s primary legal interaction is with the Industry Research and Development Act 1986 via s 33 and the specification of legislative power in s 6. All other interactions with Commonwealth financial law, administrative law, IP law, privacy law, state and territory regulatory regimes, and grant agreement terms are left to external instruments, policies and operational decisions that are not set out in the instrument itself.

The instrument itself contains an internal note about the commencement table and makes no reference to any amendments. The instrument’s amendment history, insofar as it is stated in the text supplied, is as follows.

Original making and commencement

• The instrument’s commencement table records that “The whole of this instrument” commences or is taken to have commenced the day after this instrument is registered; the information recorded under Column 3 is the date 27 June 2017 (commencement table in s 2). The instrument separately states that the table relates only to the provisions of this instrument as originally made and that it will not be amended to deal with any later amendments of this instrument. That text indicates the table is a historical record of original commencement and is not to be used as an ongoing amendment record (s 2 note).

No amendments recorded within the instrument text

• The supplied text contains no amendment clauses, no schedules of amendment, and no repeal provisions. There is no internal history of any subsequent variations, revocations, or replacements within the instrument itself.

Instruction about publication of column 3

• The instrument states that any information in column 3 of the table is not part of the instrument and that information may be inserted or edited in any published version of the instrument (s 2). This is an instruction about published versions and formatting, not an alteration of operative text. It means that published versions of the instrument may show different calendar information in column 3 without affecting the legal content of the instrument, which remains as made. That instruction also affects how one should treat revision notes in published copies.

Implication for tracking amendments

• Because the instrument itself contains no amendment schedule and instructs that the commencement table is not to be updated for later amendments, users seeking to track amendments or revocations must consult external sources: the instrument’s registration notices, the register of instruments, or consolidated legislative databases. The instrument itself does not provide a built-in amendment history.

No transitional or savings provisions included

• The instrument contains no transitional arrangements, savings clauses, expiry dates, or sunset provisions. It therefore does not record any internal changes over time. Any amendment, suspension or repeal of the instrument would therefore need to be effected by later instruments or legislative action under the Act or other relevant legal authority; none of that is captured in the text provided.

In short, the instrument records its original commencement and contains an express note limiting the commencement-table to the original instrument. It contains no internal record of amendment. To determine whether the instrument has been amended or repealed after the original registration date, one must consult external official registers or subsequent instruments.

The instrument’s text contains no reference to litigation, judicial decisions, or legal proceedings. It does not cite any cases, nor does it record any legal challenges or judicial interpretation. From the instrument itself the following points can be made.

No cases named or decisions cited

• The instrument contains no citations to judicial authority, and no references to past litigation concerning the prescription or the program (entire instrument).

No internal dispute resolution or private enforcement mechanism

• The instrument does not create specific procedures for resolving disputes arising from the programme. It therefore contains nothing that would generate a litigation history record within the instrument itself.

Implication for practitioners

• The absence of litigation references in the instrument means that any litigation concerning the operation, funding, administration or effects of the Onshore Gas Social and Economic Research Fund Program would be located in external sources: court records, administrative review decisions, or case law concerning the Industry Research and Development Act 1986 or about grant administration more generally. The instrument itself gives no textual guidance on prior judicial treatment or statutory interpretation.

How to find litigation history (practical note)

• Since the instrument does not record litigation, those seeking litigation history relevant to the programme must look beyond the instrument: at decisions under the Industry Research and Development Act 1986 (particularly s 33 matters if they have been litigated), at any litigation about grant contracts entered into by the Commonwealth in respect of the programme, or at judicial review proceedings concerning administrative action connected to the programme. The instrument itself does not identify such sources.

In summary, the instrument’s text contains no litigation history. Any judicial treatment or legal disputes related to the programme will appear in external judicial or administrative records and are not recounted in the instrument.

The instrument’s concision creates several concrete points that practitioners should note. These are not speculative criticisms; they are direct consequences of what the instrument says and does not say. Each point identifies a practical legal or administrative risk or uncertainty that flows from the text.

No funding amount, duration or payment mechanics

• The instrument prescribes a “Grant to the Commonwealth Scientific and Industrial Research Organisation” (s 5 table) but does not specify any funding amount, duration, payment schedule, or appropriation. The instrument therefore does not itself create an appropriation or authorise particular expenditures in specified sums. Users should not treat the prescription as equivalent to a grant agreement or as a statement that funds have been appropriated.

No operational or contractual terms

• There are no contractual terms, reporting requirements, performance indicators, IP ownership clauses, confidentiality rules, procurement directives or conflict-of-interest provisions within the instrument. Any obligations or entitlements of CSIRO, research partners or recipients will be contained in separate grant agreements or administrative instruments, not in this instrument.

Limited definitional scope

• The only defined term is “Act”, which is defined as the Industry Research and Development Act 1986 (s 4). Terms such as “social”, “economic”, “environmental impacts”, “onshore natural gas industry”, “research” and “communication” are not defined. This leaves room for interpretive uncertainty about the scope of permissible activities under the prescribed programme.

Prescription limited to specified legislative power

• The instrument prescribes the program “to the extent that it is with respect to the legislative power of the Parliament specified in section 6” (s 5). Section 6 specifies a particular legislative power. Practitioners should note that this limitation may constrain the legal footing for the programme; the instrument is not an unqualified prescription under all Commonwealth legislative powers.

Commencement table metadata is not operative text

• The instrument records 27 June 2017 in column 3, but expressly states that information in column 3 is not part of the instrument (s 2 note). This can be a source of confusion for users relying on printed or published copies. The operative commencement is “the day after this instrument is registered” as stated in the table column 2. Always rely on the instrument’s operative clause and registry records rather than column 3 annotations.

No stated consultation, data-sharing or jurisdictional coordination

• The subject matter (onshore natural gas) commonly engages state and territory regulators and local stakeholders. The instrument contains no process obligations for consultation, data-sharing, or coordination with other jurisdictions. Practitioners should not infer coordination mechanisms from the instrument.

Communication objective not turned into enforceable obligations

• The programme purpose includes “the communication of the results of that research” (s 5 table item (b)). The instrument does not set standards, timing or mandatory channels for communication. It may be tempting to treat communication as a guaranteed public output; the instrument does not make communication an enforceable statutory entitlement for third parties.

No enforcement, sanction or review clauses

• The absence of enforcement clauses means that remedies for alleged non-performance will depend on external contracts or general administrative law. Do not assume statutory penalties or recovery powers in this instrument.

Publication edits allowed for column 3

• The instrument permits insertion or editing of information in column 3 in published versions (s 2). That permission means published versions of the instrument may differ in their annotation and could create confusion about dates or versions. Practitioners should cross-check registration records.

Narrowness of prescription

• The instrument prescribes one programme with a narrowly framed purpose. It does not create a broader research fund or grant-making framework. Avoid assuming the instrument confers broad delegated grant-making authority beyond the specific program named.

In practice, these “gotchas” mean that to implement, challenge or advise on the programme one must look outside this instrument: at the Industry Research and Development Act 1986 for statutory mechanics, at Commonwealth appropriation records for funding, and at the actual grant agreement or administrative guidance for performance, reporting, IP and disclosure rules.

Because the instrument itself does not set out operational requirements, compliance in practice will depend on intersecting sources: the Industry Research and Development Act 1986, any grant agreement between the Commonwealth and CSIRO, and Commonwealth financial and administrative rules. The instrument does, however, create an initial legal step: the programme is prescribed and linked to a particular legislative power. For practical compliance, the following steps and checks flow from the instrument’s text.

Confirm legal basis and commencement

• Note that the instrument is made under s 33 of the Act (s 3) and that the programme is prescribed for the purposes of subsection 33(1) (s 5). The instrument commenced the day after registration (s 2). Parties implementing or participating in the programme should verify the registration details and the commencement date in the Commonwealth register to establish the operative start date.

Locate and review the grant agreement and administrative instruments

• The instrument names a “Grant to the Commonwealth Scientific and Industrial Research Organisation” as the vehicle for the programme (s 5 table). CSIRO or its contractors must locate the actual grant agreement, memoranda, schedules or administrative policy documents that set out funds, payment conditions, performance milestones, IP arrangements, reporting requirements and dispute resolution clauses. The instrument itself does not provide those terms.

Establish scope of permissible research and communication

• The programme’s purpose is defined as undertaking scientific research related to social, economic and environmental impacts of Australia’s onshore natural gas industry, and communicating the results (s 5 table). CSIRO and its partners should ensure proposed research activities fall squarely within that stated scope, and should document how outputs will satisfy the communication objective. Because key terms are undefined in the instrument, project documentation should spell out scope, methods and intended audiences to avoid interpretive disputes.

Confirm funding, appropriation and expenditure authorities

• The instrument does not appropriate funds or specify amounts. CSIRO and financial controllers should confirm that funding has been appropriated and that expenditure is authorised under the Commonwealth’s financial management framework. Do not assume funds exist simply because the programme is prescribed.

Identify reporting, publication and IP obligations

• The instrument’s communication requirement suggests outputs are intended to be disseminated (s 5 table item (b)). Parties should confirm what reporting, publication and IP obligations apply under the grant agreement or administrative rules. If publication is required, confirm timelines, formats, permissible redactions and any clearance processes. If IP arrangements are not specified in the grant agreement, seek clarity before commencing work.

Map stakeholder engagement and jurisdictional interfaces

• The research subject matter implicates industry participants, communities, and potentially state or local regulatory frameworks. Parties should plan stakeholder engagement and data-sharing protocols, and confirm whether any regulatory approvals, site access arrangements or human research ethics approvals are needed. The instrument does not mandate consultation or data-sharing frameworks.

Build administrative compliance processes

• Because the instrument does not provide enforcement or oversight mechanisms, the implementing grant agreement will. CSIRO and administrators should track milestones, financial acquittals, deliverable acceptance criteria and audit requirements specified elsewhere and ensure internal compliance systems meet those obligations.

Preserve paper trail and registration verification

• The instrument permits editing of column 3 information in published versions (s 2). Keep copies of the registered instrument from the official registry and any registration certificates. Ensure that contractual and administrative documentation references the instrument by name and registered date as necessary to evidence the legal footing for the programme.

Seek clarity on scope tied to legislative power

• The prescription is limited “to the extent that it is with respect to the legislative power of the Parliament specified in section 6” (s 5). Section 6 specifies a particular legislative power (s 6). Parties concerned about legal authority or constitutional footing should ensure that the grant’s scope and activities remain within the legal parameters identified in the instrument.

Plan for disclosure and public communication

• Since communication of results is an express program purpose (s 5), CSIRO should plan public communications consistent with the grant agreement and public interest. That includes confirming who approves public releases and ensuring compliance with privacy and confidentiality obligations that may arise from research activities, though these are not set out in the instrument.

In short, compliance with this instrument is largely about following the next-level instruments and arrangements that actually implement the prescribed programme. The instrument sets the legal prescription and object; operational compliance will depend on the grant agreement, financial authorisations and administrative rules that are not contained in this instrument.